EQS-News: aap Implantate AG / Key word(s): Personnelaap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year19.09.2025 / 22:00 CET/CESTThe issuer is solely responsible for the content of this announcement. CEO Rubino Di Girolamo has extended his contract for another three yearsCOO Agnieszka Mierzejewska will step down from the Executive Board as scheduled on December 31, 2025The CEO of aap Implantate AG ("aap" or the "Company"), Rubino Di Girolamo, has committed to another three years. CEO Rubino Di Girolamo states: "With the completion of the clinical human study of our antibacterial platform coating technology, aap is approaching a pivotal milestone. She has informed the Chair of the Supervisory Board, Dr. Nathalie Krebs, of her decision to pursue new professional opportunities. The shares of aap Implantate AG are listed in the General Standard of the Frankfurt Stock Exchange (XETRA: AAQ.DE).